VISIT US @ BOOTH #807
JOIN US FOR LUNCH!
EXHIBITOR SEMINAR:
Monday, March 23, 12-1 PM Eastern
Exhibitor Seminar Room 4, USCAP Exhibit Hall
Henry B Gonzalez Convention Center
Digital Pathology and Augmented Intelligence Transformation – To Go Fully Digital or Not?
Digital Pathology (DP) and Augmented Intelligence (AI) are reshaping clinical practice, research, and education at an accelerating pace. With over a decade of advancements behind us, now is a pivotal time to reflect on progress and chart a course for the future.
This session, designed for physicians, including pathologists, scientists, trainees, and industry professionals, brings together thought leaders from the Digital Pathology Association (DPA) to explore the practical and business dimensions of DP and AI. Speakers will address current challenges, barriers to adoption, and actionable solutions, while outlining a forward-looking framework for transformation. Attendees will also gain insight into DPA’s accomplishments and available resources. Following the presentations, a live Q&A session will provide an opportunity to engage directly with our experts. Participants are invited to connect with DPA leadership for networking and professional development opportunities.
Learning Objectives
- Rethink the approach to digital transformation in pathology
- Discuss the roadmap for implementing DP and AI in an academic setting
- Explore the essential components of integrating AI into clinical workflows
- Identify low-barrier solutions that facilitate digital adoption
- Highlight recent milestones and initiatives of DPA
Speakers
Scott Blakely
2026 DPA President
Product Development and Marketing
Hamamatsu Corporation
Digital Pathology Association Highlights
Learn about the remarkable achievements of the Digital Pathology Association (DPA) and its transformative impact on modern medicine. The DPA is a driving force in advancing the field of digital pathology, bridging the gap between cutting-edge technology and the critical practice of pathology. DPA achieves this through promoting best practices, empowering through education, fostering collaboration, advocating for standards, and much more.
Michael Grunkin, PhD
CEO and Co-founder
Visiopharm
Rethinking the Path to Diagnostic AI: Practical Solutions for Today’s Labs
Despite years of promise, adoption of digital pathology and AI has remained limited by cost, IT interoperability, complex buying processes, and the perception that full digital transformation is required. This presentation reframes the challenge by showing how AI can provide immediate diagnostic value through lower-barrier solutions and standardized approaches to interpretation. By addressing both operational realities and economic incentives, including the role of pharmaceutical partnerships, this talk highlights practical ways to bring AI into routine pathology today while building scalable pathways for the future.
Robert Stapp, DO
Associate CMIO for Pathology Informatics
Moffitt Cancer Center
How to evaluate vendors for digital pathology and AI implementation by Robert Stapp
Abstract coming soon.
Tamara Jamaspishvili, MD, PhD
Associate Professor of Pathology
Director of Pathology Research Core & Digital Pathology
(SUNY SPORE), Department of Pathology and Laboratory Medicine
Upstate Medical University
Building Roadmaps for Clinical Utility of AI: Importance of Validation and Value-Based Impact
Artificial intelligence is transforming clinical decision-making by enabling more accurate, objective, and personalized care from complex, multimodal data. Validating algorithms at scale before clinical use requires access to institutional datasets of patient cohorts to ensure generalizable and unbiased performance. Equally important is demonstrating value in outcomes and cost reduction, as future reimbursement will depend on validated, value-based evidence. This presentation will provide general insights into strategic roadmaps for validating AI-driven clinical decision tools for clinical implementation, followed by examples of collaborative AI initiatives at SUNY Upstate Medical University, which involve academic and industry partners.
MODERATOR
Marilyn M. Bui, MD, PhD
DPA Past President
Senior Member and Professor of Pathology
Scientific Director of Analytic Microscopy Core
Moffitt Cancer Center & Research Institute
This Exhibitor Seminar is not a part of the official USCAP Educational Program at the 2026 Annual Meeting, and is not sponsored by the USCAP. The USCAP does not officially endorse any company or its products and does not award CME credits for attendance at Exhibitor Seminars.
